Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000302
Chunk: 100

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 100
---
 unpaid Interest from the Issuance Date.

(4) . Any notices, consents, waivers
or other communications required or permitted to be given under the terms hereof must be in writing by letter and email and will be deemed
to have been delivered: upon the later of (A) either (i) receipt, when delivered personally or (ii) one (1) Business Day after deposit
with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same
and (B) receipt, when sent by electronic mail. The addresses and e-mail addresses for such communications shall be:

| If to the Company, to: | Biodexa Pharmaceuticals PLC             
 1 Caspian Point                         
 Caspian Way                             
 Cardiff, CF10 4DQ                       
 United Kingdom                          
 Attention: Stephen Stamp                
 E-mail: Stephen.stamp@biodexapharma.com |

| with a copy (which shall not 
 constitute notice) to:       | Mintz, Levin, Cohn, Ferris, Glovsky               
 and Popeo, P.C.                                   
 One Financial Center                              
 Boston, Massachusetts 02111                       
 Attention: Jason S. McCaffrey                     
 Email: JSMcCaffrey@mintz.com                      |
| If to the Holder:            | C/M Capital Master Fund, LP                       
 1111 Brickell Avenue                              
 Suite 2920                                        
 Miami, Florida 33131                              
 Attention: Thomas Walsh/Jonathan Juchno           
 E-mail: thomas@cm-funds.com/jonathan@cm-funds.com |
| with a copy (which shall not 
 constitute notice) to:       | Greenberg Traurig, P.A.                           
 333 S.E. 2nd Avenue, Suite 4400                   
 Miami, Florida 33131                              
 Attention: John D. Owens, III, Esq.               
 E-mail:	 jo@gtlaw.com                             |

or at such other address and/or email and/or to
the attention of such other person as the recipient party has specified by written notice given to each other party three (3) Business
Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent, waiver
or other communication, (ii) electronically generated by the sender’s email service provider containing the time, date, recipient
email address or (iii) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal